AT
Airway Therapeutics, Inc.
SEC filingBiotechnology · Marietta, GA
Amount raised$43.5Msold at filing
Total offering$50.6M$7.1M still open
Investors in the raise116count reported to the SEC
FiledSep 9, 2026first sale Aug 10, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Marc SalzbergExecutive Officer, Director
Doug LoftusDirector
Alan WolkExecutive Officer, Director
Elise Scroggs PanayotopoulousDirector
Joe Scroggs TodicscoDirector
Executive officers, directors and promoters as listed on the Form D.